Document Type
Article
Publication Date
9-2020
Abstract
The 340B drug pricing program was created to improve access to outpatient medications for low-income and underinsured r uninsured patients. It has exponentially grown with the expansion of the definition of a covered entity and the change to allow multiple contract pharmacies. Still, there are debates about the program’s financial impact and whether the discounts are passed along to enough underinsured or uninsured patients.
Recommended Citation
Maxik K, Kimble C, Coustasse A. Consider Real Costs Before Implementing a 340B Program. Pharmacy Times: Directions in Health-System Pharmacy; September, 2020;25-26.
Comments
Copyright © 2020 Pharmacy Times. Reprinted with permission. All rights reserved.